Express Scripts Holding Company (NASDAQ:ESRX) had its price objective upped by investment analysts at Morgan Stanley from $52.00 to $57.00 in a research report issued to clients and investors on Thursday. The firm presently has an “underweight” rating on the stock. Morgan Stanley’s price objective would indicate a potential downside of 5.49% from the company’s current price.

ESRX has been the subject of several other reports. ValuEngine lowered shares of Express Scripts Holding from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Mizuho cut their target price on shares of Express Scripts Holding from $76.00 to $61.00 and set a “neutral” rating for the company in a research note on Tuesday, April 25th. Needham & Company LLC started coverage on shares of Express Scripts Holding in a research note on Friday, July 21st. They set a “hold” rating for the company. Cowen and Company reissued an “outperform” rating and set a $83.00 target price on shares of Express Scripts Holding in a research note on Friday, June 9th. Finally, Evercore ISI cut their target price on shares of Express Scripts Holding from $68.50 to $59.00 and set an “in-line” rating for the company in a research note on Wednesday, April 26th. Four investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $71.17.

Shares of Express Scripts Holding (ESRX) traded down 1.47% on Thursday, hitting $60.30. The company had a trading volume of 4,302,218 shares. The stock has a market cap of $34.83 billion, a PE ratio of 10.47 and a beta of 0.90. The company has a 50-day moving average of $62.96 and a 200 day moving average of $64.58. Express Scripts Holding has a 12 month low of $57.80 and a 12 month high of $77.61.

Express Scripts Holding (NASDAQ:ESRX) last posted its quarterly earnings data on Tuesday, July 25th. The company reported $1.73 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.02. Express Scripts Holding had a net margin of 3.50% and a return on equity of 25.58%. The business had revenue of $25.35 billion during the quarter, compared to analysts’ expectations of $25.52 billion. During the same period last year, the firm posted $1.57 earnings per share. The business’s revenue was up .5% on a year-over-year basis. Analysts anticipate that Express Scripts Holding will post $6.99 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Express Scripts Holding Company (NASDAQ:ESRX) PT Raised to $57.00” was published by Daily Political and is the property of of Daily Political. If you are accessing this article on another website, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this article can be accessed at https://www.dailypolitical.com/2017/08/10/express-scripts-holding-company-nasdaqesrx-pt-raised-to-57-00.html.

In other Express Scripts Holding news, VP Phyllis S. Anderson sold 1,100 shares of the company’s stock in a transaction that occurred on Friday, May 19th. The shares were sold at an average price of $60.08, for a total value of $66,088.00. Following the transaction, the vice president now owns 11,108 shares in the company, valued at approximately $667,368.64. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 0.68% of the stock is currently owned by corporate insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Seven Eight Capital LP bought a new position in Express Scripts Holding during the second quarter valued at $644,000. Empirical Finance LLC raised its position in Express Scripts Holding by 2.4% in the second quarter. Empirical Finance LLC now owns 15,804 shares of the company’s stock valued at $1,009,000 after buying an additional 370 shares in the last quarter. Raymond James Trust N.A. raised its position in Express Scripts Holding by 3.5% in the second quarter. Raymond James Trust N.A. now owns 30,004 shares of the company’s stock valued at $1,915,000 after buying an additional 1,003 shares in the last quarter. Stephens Inc. AR raised its position in Express Scripts Holding by 15.3% in the second quarter. Stephens Inc. AR now owns 6,920 shares of the company’s stock valued at $442,000 after buying an additional 917 shares in the last quarter. Finally, CNA Financial Corp bought a new position in Express Scripts Holding during the second quarter valued at $945,000. Hedge funds and other institutional investors own 90.20% of the company’s stock.

Express Scripts Holding Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Analyst Recommendations for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.